Form D · Other Health Care
AkesoGenX Corp.
Westminster, CO · CIK 0001578909
Offering snapshot reported Jan 22, 2014 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 3, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 22, 2014 | Initial | $0 | No comparison | 3 | SEC filing |
| Jan 17, 2014 | Initial | $1,314,985 | No comparison | 1 | SEC filing |
| Jun 12, 2013 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-210458
Consideration other than cash was received in return for securities and at this time we are unable to determine the dollar value of the total offering amount or total amount sold.
Source: Form D, filed Jan 22, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Curley | Director |
| Robert Zavala | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
10955 Westmoor, Suite 400
Westminster, CO, 80021
Westminster, CO, 80021